1. Home
  2. TKNO vs NEWT Comparison

TKNO vs NEWT Comparison

Compare TKNO & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • NEWT
  • Stock Information
  • Founded
  • TKNO 1996
  • NEWT 1998
  • Country
  • TKNO United States
  • NEWT United States
  • Employees
  • TKNO N/A
  • NEWT N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • NEWT Major Banks
  • Sector
  • TKNO Health Care
  • NEWT Finance
  • Exchange
  • TKNO Nasdaq
  • NEWT Nasdaq
  • Market Cap
  • TKNO 390.7M
  • NEWT 365.7M
  • IPO Year
  • TKNO 2021
  • NEWT N/A
  • Fundamental
  • Price
  • TKNO $8.66
  • NEWT $13.42
  • Analyst Decision
  • TKNO Buy
  • NEWT Hold
  • Analyst Count
  • TKNO 2
  • NEWT 3
  • Target Price
  • TKNO $5.00
  • NEWT $14.33
  • AVG Volume (30 Days)
  • TKNO 227.3K
  • NEWT 121.8K
  • Earning Date
  • TKNO 11-07-2024
  • NEWT 11-06-2024
  • Dividend Yield
  • TKNO N/A
  • NEWT 5.73%
  • EPS Growth
  • TKNO N/A
  • NEWT 22.62
  • EPS
  • TKNO N/A
  • NEWT 1.68
  • Revenue
  • TKNO $36,347,000.00
  • NEWT $316,405,000.00
  • Revenue This Year
  • TKNO $3.47
  • NEWT N/A
  • Revenue Next Year
  • TKNO $12.07
  • NEWT $6.55
  • P/E Ratio
  • TKNO N/A
  • NEWT $7.89
  • Revenue Growth
  • TKNO N/A
  • NEWT 38.64
  • 52 Week Low
  • TKNO $1.16
  • NEWT $10.07
  • 52 Week High
  • TKNO $8.91
  • NEWT $15.49
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 62.73
  • NEWT 37.45
  • Support Level
  • TKNO $7.56
  • NEWT $14.02
  • Resistance Level
  • TKNO $8.89
  • NEWT $14.44
  • Average True Range (ATR)
  • TKNO 0.64
  • NEWT 0.38
  • MACD
  • TKNO 0.05
  • NEWT -0.14
  • Stochastic Oscillator
  • TKNO 84.58
  • NEWT 7.78

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

About NEWT NewtekOne Inc.

NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.

Share on Social Networks: